DK0640081T3 - Substituerede phenylcarbarmater og phenylurinstoffer, deres fremstilling og deres anvendelse som 5-HT4-antagonister - Google Patents

Substituerede phenylcarbarmater og phenylurinstoffer, deres fremstilling og deres anvendelse som 5-HT4-antagonister

Info

Publication number
DK0640081T3
DK0640081T3 DK93908861T DK93908861T DK0640081T3 DK 0640081 T3 DK0640081 T3 DK 0640081T3 DK 93908861 T DK93908861 T DK 93908861T DK 93908861 T DK93908861 T DK 93908861T DK 0640081 T3 DK0640081 T3 DK 0640081T3
Authority
DK
Denmark
Prior art keywords
substituted
preparation
phenylcarbarmates
phenylureas
antagonists
Prior art date
Application number
DK93908861T
Other languages
Danish (da)
English (en)
Inventor
Alexander William Oxford
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929206989A external-priority patent/GB9206989D0/en
Priority claimed from GB929217827A external-priority patent/GB9217827D0/en
Priority claimed from GB929221718A external-priority patent/GB9221718D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK0640081T3 publication Critical patent/DK0640081T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK93908861T 1992-03-31 1993-03-26 Substituerede phenylcarbarmater og phenylurinstoffer, deres fremstilling og deres anvendelse som 5-HT4-antagonister DK0640081T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929206989A GB9206989D0 (en) 1992-03-31 1992-03-31 Chemical compounds
GB929217827A GB9217827D0 (en) 1992-08-21 1992-08-21 Chemical compounds
GB929221718A GB9221718D0 (en) 1992-10-16 1992-10-16 Chemical compounds
PCT/EP1993/000779 WO1993020071A1 (en) 1992-03-31 1993-03-26 Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht antagonists

Publications (1)

Publication Number Publication Date
DK0640081T3 true DK0640081T3 (da) 2000-06-19

Family

ID=27266122

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93908861T DK0640081T3 (da) 1992-03-31 1993-03-26 Substituerede phenylcarbarmater og phenylurinstoffer, deres fremstilling og deres anvendelse som 5-HT4-antagonister

Country Status (17)

Country Link
EP (2) EP0972773A1 (cs)
JP (1) JP3236298B2 (cs)
AT (1) ATE188697T1 (cs)
AU (1) AU663780B2 (cs)
CA (1) CA2133083A1 (cs)
CZ (1) CZ236894A3 (cs)
DE (1) DE69327583T2 (cs)
DK (1) DK0640081T3 (cs)
ES (1) ES2141763T3 (cs)
FI (1) FI944513A7 (cs)
GR (1) GR3032877T3 (cs)
HU (1) HUT72321A (cs)
NO (1) NO943631L (cs)
NZ (1) NZ251687A (cs)
PT (1) PT640081E (cs)
SK (1) SK116394A3 (cs)
WO (1) WO1993020071A1 (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU685225B2 (en) * 1994-02-10 1998-01-15 Yamanouchi Pharmaceutical Co., Ltd. Novel carbamate derivative and medicinal composition containing the same
FR2750991A1 (fr) * 1996-07-12 1998-01-16 Pf Medicament Nouveaux benzodioxannes et 1-(2h)-benzopyrannes, leur preparation et leur utilisation comme medicament
FR2752732B1 (fr) 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
US6693202B1 (en) 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
UA73543C2 (uk) * 1999-12-07 2005-08-15 Тераванс, Інк. Похідні сечовини, фармацевтична композиція та застосування похідного при приготуванні лікарського засобу для лікування захворювання, яке опосередковується мускариновим рецептором
DE60021282T2 (de) 1999-12-07 2006-05-18 Theravance, Inc., South San Francisco Carbamat-derivate als muscarin-rezeptor antonisten
CA2418904A1 (en) * 2000-08-07 2002-02-14 Laboratoire Glaxosmithkline S.A.S. Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
AU2001280187A1 (en) * 2000-08-28 2002-03-13 Toray Industries, Inc. Cyclic amine derivatives
FR2821356A1 (fr) * 2001-02-23 2002-08-30 Cerep Nouveaux derives d'arylcarbamates et d'arylurees, preparations et utilisations
FR2843750B1 (fr) * 2002-08-23 2004-10-22 Cerep Composes derives d'arylcarbamates, preparation et utilisations
PE20040950A1 (es) 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
ES2329586T3 (es) 2003-11-21 2009-11-27 Theravance, Inc. Compuestos que tienen actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarino.
WO2006023457A1 (en) 2004-08-16 2006-03-02 Theravance, Inc. COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
WO2006023460A2 (en) 2004-08-16 2006-03-02 Theravance, Inc. COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
GB0602778D0 (en) 2006-02-10 2006-03-22 Glaxo Group Ltd Novel compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA76475B (en) * 1975-03-10 1977-08-31 Ciba Geigy Ag Indolyalkylpiperidines
JPH0140026B2 (cs) * 1978-07-03 1989-08-24 Amerikan Hoomu Purodakutsu Corp
AU611976B2 (en) * 1987-12-24 1991-06-27 John Wyeth & Brother Limited Aroyl urea and carbamic acid derivatives of azabicyclo compounds
DK443489D0 (da) * 1989-09-08 1989-09-08 Ferrosan As Substituerede urinstofforbindelser, deres fremstilling og anvendelse
FR2677019B1 (fr) * 1991-05-27 1994-11-25 Pf Medicament Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
FR2679555B1 (fr) * 1991-07-25 1993-11-19 Fabre Medicament Pierre Nouveaux derives de l'uree, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
CZ236894A3 (en) 1995-09-13
CA2133083A1 (en) 1993-10-14
GR3032877T3 (en) 2000-07-31
JP3236298B2 (ja) 2001-12-10
PT640081E (pt) 2000-05-31
FI944513A0 (fi) 1994-09-29
ATE188697T1 (de) 2000-01-15
NO943631D0 (no) 1994-09-29
NZ251687A (en) 1995-12-21
JPH07505868A (ja) 1995-06-29
ES2141763T3 (es) 2000-04-01
AU3949793A (en) 1993-11-08
FI944513A7 (fi) 1994-11-29
HU9402825D0 (en) 1994-12-28
NO943631L (no) 1994-11-29
WO1993020071A1 (en) 1993-10-14
AU663780B2 (en) 1995-10-19
DE69327583D1 (de) 2000-02-17
HUT72321A (en) 1996-04-29
SK116394A3 (en) 1995-04-12
EP0972773A1 (en) 2000-01-19
DE69327583T2 (de) 2000-05-31
EP0640081B1 (en) 2000-01-12
EP0640081A1 (en) 1995-03-01

Similar Documents

Publication Publication Date Title
DK0640081T3 (da) Substituerede phenylcarbarmater og phenylurinstoffer, deres fremstilling og deres anvendelse som 5-HT4-antagonister
IE901040L (en) N-(3-hydroxy-4-piperidinyl)(dihydro-benzofuran,¹dihydro-2h-benzopyran or dihydrobenzodioxin)carboxamide¹derivatives
DK0568306T3 (da) Anitkonvulsive fructopyranose cycliske sulfitter og sulfater
EP0291917A3 (en) Novel oxetanocins
ES2037768T3 (es) Procedimiento para preparar n-(fenil(2,6-disustituido))-ureas y carbamatos inhibidores de acil-coa: colesterol acil-transferasa.
ES8105274A1 (es) Un procedimiento para la preparacion de derivados de acido benceno -1,2,-disulfonico.
DK0572782T3 (da) 1-Aryl-3-(3,4-dihydro-4-oxo-3-quinazolinyl)-urinstoffer og deres anvendelse som fungicider
DK719388A (da) Propoxybenzenderivater og fremgangsmaade til fremstilling deraf
ES8402566A1 (es) Procedimiento para preparar fenilsulfonilisocianatos sustituidos.
ATE372328T1 (de) Angiogenese-hemmende 5-substituierte-1,2,4- thiadiazolylderivate
DK266686D0 (da) 1-aryl-5-alkoximinoalkylaminopyrazoler, fremgangsmaader til fremstilling deraf og deres anvendelse som herbicider og vaekstregulatorer
DK121484A (da) 3-(pyrimidin-5-yloxyphenyl)-1-benzoyl-(thio)-urinstoffer, deres fremstilling og mellemprodukter hertil samt deres anvendelse som skadedyrsbekaempelsesmiddel
ES2158290T3 (es) Derivados de tiazolidinona opticamente activos.
FI844552L (fi) Aralkyl(aryletynyl)aralkyl-aminer och deras anvaendning som blodkaerlsutvidgande och blodtryckssaenkande medel.
NL950025I2 (nl) Nieuwe alfa, alfa-diaryl-4-aryl-4-hydroxy-1-piperidinebutanamide.
DE68923231D1 (de) Antihypertensive 3-Piperidinylindazol-Derivate.
DK0661275T3 (da) 1-( alfa-Cyclopropyl-alfa-(substitueret oxy)-otolyl sulfamoyl) -3-(4,6-dimethoxy-2-pyrimidinyl) urinstoffer som herbicide midler.
DK0566557T3 (da) 2- og 3-amino- og azidoderivater af 1,5- iminosukkere som antivirale forbindelser
NO179835C (no) Aminderivater med fungicid aktivitet og anvendelse som fungicider
DE68910736D1 (de) Fungizide heterozyklische Stickstoffverbindungen.
DK0842159T3 (da) Fremgangsmåde til fremstilling af herbicide sulfonylurinstoffer og af N-(pyrimidinyl- eller -triazinyl)-carbamater som mell